EFTA Document EFTA02100345

To: From: Sent Thur 5129/2014 2:02:20 PM Subject Re: Confidential James, I am so sorry to do this, but Jeffrey must cancel his appointment with you and David Carter on Sunday June I...he is ill and says he will reschedule for later in the month... Once again, so sorry for any inconvenience. On May 21, 2014, at 6:05 PM, James Meiskin wrote: Confirmed. Thank you Sent from my iPhone On May 21, 2014, at 5:51 PM, wrote: Jeffrey's home, 9 East 71st Street between 5th and Madison... 5pm would be great. On May 21, 2014, at 5:14 PM, James Meiskin ce wrote: That will work. Do you have a time and location in mind? Thank you, James Sent from my iPhone On May 21, 2014, at 10:25 AM, wrote: Great. Would Sunday June 1st work? Sent from my iPhone On May 21, 2014, at 9:47 AM, James Meiskin wrote: Of course. Please get me dates that work for Jeffrey, and I will EFTA_R1_00707056 EFTA02100345 have David fly in from CA to meet him with pleasure. Hope your well Best, James Sent from my iPhone On May 21, 2014, at 9:41 AM, IM > wrote: HI James....below is Jeffrey's response: im not in ny until june but happy to see you both after Might it be possible to schedule something the beginning of June? On May 21, 2014, at 9:23 AM, "James Meiskin" .> wrote: Jeffrey , David Carter (Comp any inform ation is attach ed). is in NY today and tomorr ow mornin g. and I felt that it could EFTA_R1_00707057 EFTA02100346 be benefi cial and timely for you to further learn about this opport unity if there was interes t on your end. Please take a mome nt to review the attach ed materi al. and let me know if you would like to meet while David is in NYC. Best Regar ds, James Dear James, Like I have said in an earlier email. I am looking for an "investing partner" to match (50%/50%) EFTA_R1_00707058 EFTA02100347 the money Russian Venture Capital plans to invest in USA based Biotechnology. They will provide half of the capital to develop a variety of technologies that are of interest to their country. For their investment they get commercialization rights to the technologies they finance for Russia and the CIS. For us, on the USA side, this is a major source of capital to start a series of companies that have great potential as therapeutic technologies, and we get commercialization rights for the USA, and rest of the world markets. Basically, we get the rights that are valuable to us at "half price". Over the next several years our plan is to identify seven/eight technologies that are worthy of development. RVC has already agreed to finance the first (MALI) and is looking at the next two—Prediction Biosciences, and OvationBio. I have several more currently in diligence. (The original Investor Presentation made in Moscow is attached) So, I am looking for a source of capital that thinks this is an interesting investment theme, and is willing to consider the idea as something they might want to implement. My belief is that there is more money in NYC, seeking an investment home, then there are "quality investment ideas". I could be wrong, but I have to believe that people running a lot of capital in New York would want to hear new, creative, and GOOD new investment ideas. I think this idea is the kind of idea that is worth a look, and worth serious consideration. I think we are talking $150M over a five year horizon. Best, David David W. Carter President—DaCart Capital U.0 <DaC art Prese ntatio n.pptx EFTA_R1_00707059 EFTA02100348 > E FTA_R 1_00707 060 EFTA02100349